|Page (1) of 1 - 05/10/12||email article||print page|
Quanticate Expands Operations in India and Its Commitment to Provide High Quality, Effective Data-Related CRO Services to Support Clinical Trials(May 10, 2012)
LONDON and CAMBRIDGE, MA -- (Marketwire) -- 05/10/12 -- Quanticate, a leading global data-focused clinical research organization (CRO), today announced expansion of its capabilities in India with the opening of a new office in Bangalore, India.
"Expansion of our facility in India is in direct response to the requirements of our customers and the driving force that enabled us to significantly grow in this region," explained Daniel Chapple, Executive Vice President and Chief Commercial Officer at Quanticate. "Research has shown that customers turn to Quanticate because of our experience, knowledge and the high quality that we offer. Now through this expansion, our customers will also benefit from even more cost effective offerings, particularly with the large-scale FSPs that we have in place," said Chapple.
India, along with other lower cost locations, have become integral to the greater adoption of outsourcing approaches especially since price remains one key consideration in the decision making process. However, ensuring that the operational structure keeps overall costs at an optimal level when taking into account oversight, communication and quality control at both the CRO and customer side, is a critical element to successfully provide support and solutions to the pharmaceutical, biotechnology, device and nutrition industries.
Karen Ooms, Executive Vice President of Operations (Strategic Delivery), explains, "Quanticate has been careful in its approach to using lower cost regions and does so for more than the purpose of achieving more attractive labor rates due to the importance and cost of gaining the data. The employees that are working in all our sites are not only highly experienced but also have a focus on teamwork to ensure that the high quality deliverables and communication that Quanticate has a reputation for is not impacted. We anticipate that all our locations will continue to grow based upon the high sales growth that we experienced in the last two quarters and our healthy pipeline," said Ooms. "This is an exciting time at Quanticate as we have recently launched our centralized data solution and we have been adding new expertise and technologies to support both our customers and our growing number of highly skilled statisticians, programmers, data managers, medical writers and pharmacovigilance experts."
Quanticate, with headquarters in the UK and USA, is a specialist Clinical Research Organization (CRO) primarily focused on the management, analysis and reporting of data from clinical trials and post-marketing surveillance. Our team has a passion for excellence and we provide high quality, efficient outsourcing solutions for companies who need additional capacity, study level support or who want to outsource certain functions in their entirety. Services include scalable on-site and off-site data management, statistical consultancy, statistical programming & analysis, medical writing and pharmacovigilance to support both the clinical and safety requirements of our customers. For more news and information, visit www.quanticate.com
Ripple Effect Communications
Copyright @ Marketwire
Related Keywords: Quanticate, USA, India, Marketwire, , Medical, india, Other,